Background/aims: There is emerging evidence of gabapentin and pregabalin (gabapentinoid) abuse, particularly in the substance misuse population, and some suggestion of gabapentinoids being abused alongside methadone.

Methods: A questionnaire-based survey was carried out in six substance misuse clinics, looking for evidence of gabapentinoid abuse.

Results: 22% (29/129) of respondents admitted to abusing gabapentinoids, and of these, 38% (11/29) abused gabapentinoids in order to potentiate the 'high' they obtained from methadone.

Conclusions: Gabapentinoid abuse along with methadone has not previously been described. These findings are of relevance to clinicians working within both substance misuse services and chronic pain services.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000355268DOI Listing

Publication Analysis

Top Keywords

gabapentinoid abuse
12
substance misuse
12
order potentiate
8
gabapentinoid
4
abuse order
4
potentiate methadone
4
methadone survey
4
substance
4
survey substance
4
substance misusers
4

Similar Publications

Perceptions of community pharmacists regarding pregabalin abuse: a survey from Sudan.

Int J Pharm Pract

December 2024

Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman, Jordan.

Objectives: Pregabalin abuse is increasing in prevalence and is associated with significant harm. This study aimed to assess community pharmacists' perceptions of pregabalin abuse and their recommendations to address this issue.

Methods: This was a descriptive cross-sectional study conducted in the Omdurman locality, Khartoum in 2022.

View Article and Find Full Text PDF
Article Synopsis
  • The study was a retrospective cohort analysis aimed at assessing the impact of gabapentinoids on opioid use after anterior lumbar interbody fusion surgery.
  • While gabapentinoid treatment led to a slight 2.9% reduction in daily opioid consumption, it paradoxically increased the total duration and amount of opioids prescribed significantly (37.1% and 41.7%, respectively).
  • Additionally, the use of gabapentinoids was linked to higher risks of pain-related readmissions and potential drug abuse.
View Article and Find Full Text PDF

Introduction: This study assesses the association of preoperative use of gabapentinoids (GBPs) with postoperative risk of opioid-related disorders in peripheral artery disease patients undergoing lower extremity bypass operation.

Methods: This is a retrospective propensity score-matched analysis of patients undergoing peripheral artery bypass in TriNetX, a multicenter national database. Two study groups were constituted based on the preoperative history of prescribed GBPs.

View Article and Find Full Text PDF

Characteristics of Non-Therapeutic Pregabalin Users Detected by a Community Pharmacies Network in a Region of Southern Europe.

J Clin Med

October 2024

Physiology Section, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain.

: Since 2008, several cases of pregabalin abuse have been reported to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Despite this evidence, gabapentinoids are increasingly being prescribed. Moreover, pregabalin is being used in a recreational setting for its dissociative effects and euphoria.

View Article and Find Full Text PDF
Article Synopsis
  • Gabapentinoids, widely prescribed for pain, have been linked to misuse and dependence, prompting a systematic review of qualitative research on this issue.* -
  • The review analyzed 26 high-quality studies, revealing motives for misuse such as seeking euphoria, self-medicating, and dealing with withdrawal symptoms, along with symptoms of dependence including tolerance and severe withdrawal effects.* -
  • Findings indicate significant public health concerns regarding gabapentinoid use, as misuse can lead to harmful effects like overdose and psychiatric issues, highlighting the need for careful prescribing practices.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!